Genmab A/S (GNMSF) Stock Chart & Stock Price History → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free GNMSF Stock Alerts $279.60 -10.74 (-3.70%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Genmab A/S Stock Price Performance5 Day Performance-1.74%1 Month Performance-7.29%3 Month Performance+1.30%6 Month Performance-2.14%Year-To-Date Performance-11.43%1 Year Performance-31.69% Receive GNMSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! GNMSF Stock Chart for Thursday, April, 25, 2024 GNMSF Chart by TradingView Genmab A/S Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$290.34$279.60-3.70%$290.40$275.551,217 shs$18.28 billion04/23/2024$289.67$290.34+0.23%$294.54$279.36343 shs$0.0004/22/2024$284.55$289.67+1.80%$290.53$279.765,321 shs$0.0004/19/2024$290.38$284.55-2.01%$288.30$283.30241 shs$0.0004/18/2024$281.02$290.38+3.33%$290.38$279.82179 shs$0.0004/17/2024$285.11$281.02-1.43%$292.85$278.65212 shs$0.00 Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$282.00$285.11+1.10%$295.94$285.11416 shs$0.0004/15/2024$291.12$282.00-3.13%$295.59$278.46206 shs$0.0004/12/2024$298.16$291.12-2.36%$297.01$290.92145 shs$0.0004/11/2024$296.00$298.16+0.73%$298.80$294.75675 shs$19.49 billion04/10/2024$296.00$296.00$302.35$289.77364 shs$19.35 billion04/09/2024$293.25$296.00+0.94%$300.90$296.00360 shs$0.0004/08/2024$297.17$293.25-1.32%$303.71$291.92364 shs$0.0004/05/2024$297.17$297.17$304.20$293.251,153 shs$0.0004/04/2024$292.17$297.17+1.71%$306.55$297.171,153 shs$0.0004/03/2024$299.50$292.17-2.45%$297.85$290.51398 shs$0.0004/02/2024$295.72$299.50+1.28%$302.97$293.76155 shs$0.0004/01/2024$306.59$295.72-3.55%$306.83$292.15866 shs$0.0003/29/2024$306.59$306.59$306.59$296.361,205 shs$0.0003/28/2024$301.00$306.59+1.86%$306.59$296.361,205 shs$0.0003/27/2024$307.00$301.00-1.95%$310.56$299.49277 shs$0.0003/26/2024$301.60$307.00+1.79%$308.50$302.14379 shs$0.0003/25/2024$298.00$301.60+1.21%$304.90$293.95308 shs$19.72 billion03/22/2024$294.90$298.00+1.05%$306.32$290.92417 shs$0.0003/21/2024$289.72$294.90+1.79%$298.61$289.82103 shs$0.0003/20/2024$295.00$289.72-1.79%$300.88$286.40177 shs$0.0003/19/2024$297.31$295.00-0.78%$296.90$292.16166 shs$0.0003/18/2024$301.60$297.31-1.42%$301.09$296.05944 shs$0.0003/15/2024$301.53$301.60+0.02%$307.42$291.65619 shs$0.0003/14/2024$313.00$301.53-3.67%$318.12$301.53193 shs$0.0003/13/2024$311.50$313.00+0.48%$323.02$310.8992 shs$0.0003/12/2024$312.60$311.50-0.35%$317.48$305.60224 shs$0.0003/11/2024$298.60$312.60+4.69%$315.90$305.061,254 shs$20.43 billion03/08/2024$292.60$298.60+2.05%$305.94$293.07821 shs$0.0003/07/2024$293.58$292.60-0.33%$295.72$291.50150 shs$0.0003/06/2024$284.90$293.58+3.05%$294.00$283.44429 shs$0.0003/05/2024$283.58$284.90+0.47%$288.90$283.10246 shs$0.0003/04/2024$290.00$283.58-2.21%$291.92$283.58830 shs$0.0003/01/2024$278.41$290.00+4.16%$294.40$285.501,557 shs$0.0002/29/2024$275.08$278.41+1.21%$282.00$275.321,865 shs$0.00The system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here!02/28/2024$292.20$275.08-5.86%$288.23$275.0821,360 shs$0.0002/27/2024$288.80$292.20+1.18%$292.20$285.50219 shs$0.0002/26/2024$287.90$288.80+0.31%$295.50$287.50973 shs$18.88 billion02/23/2024$287.60$287.90+0.10%$294.20$287.50377 shs$0.0002/22/2024$287.00$287.60+0.21%$293.90$287.501,081 shs$0.0002/21/2024$286.01$287.00+0.35%$291.54$285.16276 shs$0.0002/20/2024$286.20$286.01-0.07%$291.50$286.001,104 shs$0.0002/19/2024$286.20$286.20$291.30$282.80600 shs$0.0002/16/2024$287.40$286.20-0.42%$291.30$282.80629 shs$18.71 billion02/15/2024$272.50$287.40+5.47%$293.10$280.501,207 shs$0.0002/14/2024$262.26$272.50+3.90%$281.48$266.502,573 shs$0.0002/13/2024$273.20$262.26-4.00%$269.60$262.00685 shs$0.0002/12/2024$274.50$273.20-0.47%$280.80$270.50549 shs$0.0002/09/2024$273.70$274.50+0.29%$280.20$273.00320 shs$0.0002/08/2024$276.80$273.70-1.12%$279.20$273.70388 shs$0.0002/07/2024$277.90$276.80-0.40%$282.20$276.53956 shs$0.0002/06/2024$276.40$277.90+0.54%$283.60$275.80352 shs$18.07 billion02/05/2024$276.27$276.40+0.05%$276.80$270.50679 shs$0.0002/02/2024$280.80$276.27-1.61%$279.44$273.301,328 shs$0.0002/01/2024$277.30$280.80+1.26%$280.80$274.00382 shs$0.0001/31/2024$279.30$277.30-0.72%$283.10$277.30384 shs$0.0001/30/2024$275.90$279.30+1.23%$284.70$278.00249 shs$0.0001/29/2024$276.20$275.90-0.11%$281.10$274.50912 shs$0.0001/26/2024$276.00$276.20+0.07%$282.20$276.201,181 shs$0.0001/25/2024$272.20$276.00+1.40%$282.00$276.00626 shs$0.0001/24/2024$279.35$272.20-2.56%$279.60$272.20259 shs$0.00 Related Companies: Abliva AB (publ) Stock Chart Acusphere Stock Chart Aeolus Pharmaceuticals Stock Chart Affymax Stock Chart Alseres Pharmaceuticals Stock Chart American Bio Medica Stock Chart American Oriental Bioengineering Stock Chart Anthera Pharmaceuticals Stock Chart ARYx Therapeutics Stock Chart AXM Pharma Stock Chart Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GNMSF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.